How is advanced kidney cancer treated?
Apr 21, 2022
Source: Cainiu Health
Dr. Peng Xiaodong
Introduction
How is advanced renal cell carcinoma treated? In advanced renal cell carcinoma, cancer cells have already metastasized, necessitating targeted therapy. Commonly used targeted agents include sorafenib, axitinib, sunitinib, and bevacizumab. Additionally, patients with advanced renal cell carcinoma may undergo ablation therapy—using ultrasound, CT, or other imaging modalities for precise tumor localization, followed by physical or chemical methods to directly destroy the tumor tissue.
Renal cell carcinoma (RCC) is a malignant tumor originating from the epithelial cells of the renal tubules in the kidney parenchyma. It is typically asymptomatic in its early stages; however, in advanced stages, a minority of patients may present with hematuria, an abdominal mass, or flank pain. The precise etiology remains unclear but may involve factors such as obesity, smoking, and genetic predisposition. Prompt treatment is essential upon diagnosis.
How Is Advanced-Stage Renal Cell Carcinoma Treated?
1. Pharmacotherapy
In advanced-stage RCC, cancer cells have usually metastasized, necessitating targeted drug therapy—the standard treatment for metastatic RCC. Commonly used targeted agents include sorafenib, axitinib, sunitinib, bevacizumab, lenvatinib, pazopanib, temsirolimus, and everolimus. These agents are also indicated for unresectable clear-cell renal cell carcinoma. Efficacy varies among drugs, and combination regimens are often required to achieve optimal therapeutic outcomes.
2. Ablative Therapy
Ablative therapy is another option for patients with advanced RCC. Under image guidance—such as ultrasound, CT, or MRI—the tumor is precisely localized, and physical or chemical methods are then applied directly to destroy the tumor tissue. Common ablative modalities include radiofrequency ablation and cryoablation. Studies show no significant differences between these two techniques regarding overall survival, cancer-specific survival, recurrence-free survival, or complication rates.
3. Comprehensive (Multimodal) Therapy
For patients with advanced RCC, a multimodal treatment approach is often adopted. In selected patients with good performance status and distant metastases, palliative nephrectomy may be performed to enhance the efficacy of subsequent systemic drug therapy.
The above outlines current treatment strategies for advanced-stage renal cell carcinoma. Treatment plans must be individualized based on each patient’s physical condition, socioeconomic circumstances, and other relevant factors. While these approaches cannot guarantee cure, they can effectively alleviate symptoms, control disease progression, and prolong survival. We hope this information is helpful to you.
